4.5 Article

Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy

Zhen Ren et al.

Summary: The study found that breast cancer patients with similar kinetic parameters in ipsi- and contra-lateral normal parenchyma before NAT were more likely to achieve pathologic complete response. Patients classified as RCB II after NAT showed higher values in normal parenchyma and tumor kinetics.

ACADEMIC RADIOLOGY (2022)

Article Oncology

Breast Cancer, Version 3.2022

William J. Gradishar et al.

Summary: This article discusses the complex therapeutic options for patients with noninvasive or invasive breast cancer, as well as the recommendations provided by the NCCN Clinical Practice Guidelines for Breast Cancer. It focuses on the overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Multiparametric imaging of breast cancer: An update of current applications

Masako Kataoka et al.

Summary: Imaging plays a crucial role in the diagnosis and treatment of breast cancer. Various new imaging tools are being developed to enhance diagnostic performance and evaluate tumor response. It is important for breast imaging experts to understand the advantages and limitations of these new techniques in order to provide optimal imaging for each patient.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies

Toulsie Ramtohul et al.

Summary: The study aimed to evaluate whether semiquantitative perfusion parameters calculated at initial ultrafast DCE MRI can predict pathologic response after neoadjuvant chemotherapy in breast cancer patients. The results showed that the wash-in slope (WIS) parameter was an independent predictor associated with pathologic complete response, and it could differentiate subgroups of breast cancer patients with different rates of pathologic complete response.

RADIOLOGY (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

How to report and compare quantitative variables in a radiology article

Maxime Barat et al.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2022)

Article Oncology

Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer

Xinhong Liang et al.

Summary: The combination of ADC values and DCE-MRI parameters, especially the combination of W-in, TTP, and ADC values, may improve the early prediction of pCR in breast cancer.

BMC CANCER (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness

Sung Ui Shin et al.

EUROPEAN RADIOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer

Beatriu Reig et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers

Rubina Manuela Trimboli et al.

RADIOLOGIA MEDICA (2018)

Article Anatomy & Morphology

The Long-term Prognostic Performance of Ki-67 in Primary Operable Breast Cancer and Evaluation of Its Optimal Cutoff Value

Uiju Cho et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening High-Resolution Ultrafast Dynamic Imaging

Ritse M. Mann et al.

INVESTIGATIVE RADIOLOGY (2014)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Model-free parameters from dynamic contrast-enhanced-MRI: Sensitivity to EES volume fraction and bolus timing

John A. Jesberger et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)

Review Oncology

Redefining the target: Chemotherapeutics as antiangiogenics

KD Miller et al.

JOURNAL OF CLINICAL ONCOLOGY (2001)